RESMED Aktie

 

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

The company has reported solid revenue and earnings growth. Here's what I make of its performance and current valuation. The post Would I buy ResMed shares after today's results? appeared first on The Motley Fool Australia....

ResMed (RMD) delivered earnings and revenue surprises of +8.99% and +1.66%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?...

Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

WASHINGTON (dpa-AFX) - Resmed Inc (RMD.AX) released a profit for its first quarter that Increases, from last yearThe company's bottom line totaled $418.413 million, or $2.92 per share. This compar......

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Note: A webcast of Resmed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com...

Here's my verdict on whether I'd buy shares before the announcement. The post Are ResMed shares a strong buy before its results on Friday? appeared first on The Motley Fool Australia....

Rider, Michael J. - Vorstand - Tag der Transaktion: 2026-10-23...

ResMed (RMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report....

RMD heads into Q1 fiscal 2027 earnings with sleep device demand and new product launches supporting growth, while MatrixCare's divestiture weighs on revenues....

ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....

Let's check out some new ratings from Bell Potter, Ord Minnett, and Morgans. The post Buy, hold, sell: Bank of Queensland, Champion Iron, Resmed shares appeared first on The Motley Fool Australia....

The top broker explains its buy recommendations on Fortescue, ARB, and Resmed shares. The post 3 ASX 200 shares to buy and why: Ord Minnett appeared first on The Motley Fool Australia....

Let's start the week with some fresh ratings from the experts.  The post Buy, hold, sell: Resmed, Megaport, ANZ shares appeared first on The Motley Fool Australia....

Farrell, Michael J. - Vorstand - Tag der Transaktion: 2026-10-07...

How do ResMed and Fisher & Paykel compare on value, income, and share price momentum? Here's my verdict on which is the better buy. The post ResMed vs Fisher & Paykel Healthcare: Which is better value? appeared first on The Motley Fool Australia....

SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2027 on Thursday, October 29, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast....

I look at what the next few years of earnings growth could mean for today's valuation. The post Is the ResMed share price a cheap buy? appeared first on The Motley Fool Australia....

This sector is coming back into favour. The post CSL, Resmed, and more. See which ASX health stocks RBC Capital Markets has upgraded appeared first on The Motley Fool Australia....